| VA vs DA for Newly Diagnosed Hig-risk AML (NCT05939180) | The First Affiliated Hospital of Soochow University | 2024-04-01 |
| Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL (NCT06507514) | The First Affiliated Hospital of Soochow University | 2024-04-01 |
| Repetitive Transcranial Magnetic Stimulation Attenuates Visceral Pain in Irritable Bowel Syndrome With Diarrhea (NCT06409078) | The First Affiliated Hospital of Soochow University | 2024-04-01 |
| Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients (NCT06394011) | The First Affiliated Hospital of Soochow University | 2024-02-15 |
| VAC Regimen for AML Patients Who Failed to Response to VA Regimen (NCT06220162) | The First Affiliated Hospital of Soochow University | 2024-02-01 |
| Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALL (NCT06578546) | The First Affiliated Hospital of Soochow University | 2024-02-01 |
| Efficacy, Safety, and Pharmacokinetics of ThisCART19A Combined With Olverembatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. (NCT07074496) | The First Affiliated Hospital of Soochow University | 2024-01-01 |
| Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML (NCT06429098) | The First Affiliated Hospital of Soochow University | 2024-01-01 |
| Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma (NCT06381830) | The First Affiliated Hospital of Soochow University | 2024-01-01 |
| TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT (NCT06125483) | The First Affiliated Hospital of Soochow University | 2023-11-01 |
| An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma (NCT05980507) | The First Affiliated Hospital of Soochow University | 2023-10-09 |
| Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies (NCT06041815) | The First Affiliated Hospital of Soochow University | 2023-09-03 |
| A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma (NCT04923789) | The First Affiliated Hospital of Soochow University | 2023-09-01 |
| A Registry for Patients With Systemic Mastocytosis in China (NCT06013683) | The First Affiliated Hospital of Soochow University | 2023-09-01 |
| Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients (NCT06544109) | The First Affiliated Hospital of Soochow University | 2023-08-01 |
| Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT (NCT05669079) | The First Affiliated Hospital of Soochow University | 2023-08-01 |
| The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation (NCT05907486) | The First Affiliated Hospital of Soochow University | 2023-08-01 |
| Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL (NCT06468943) | The First Affiliated Hospital of Soochow University | 2023-07-01 |
| A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL (NCT05931757) | The First Affiliated Hospital of Soochow University | 2023-07-01 |
| Decitabine for Poor Graft Function Post Allo-HSCT (NCT05907499) | The First Affiliated Hospital of Soochow University | 2023-07-01 |
| TFBC Combined With UCBT in the Treatment of High-risk Malignant Hematological Diseases (NCT05929092) | The First Affiliated Hospital of Soochow University | 2023-06-01 |
| Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients (NCT05805072) | The First Affiliated Hospital of Soochow University | 2023-05-01 |
| Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients (NCT05855122) | The First Affiliated Hospital of Soochow University | 2023-04-17 |
| CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia (NCT05822037) | The First Affiliated Hospital of Soochow University | 2023-04-12 |
| Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China (NCT05789615) | The First Affiliated Hospital of Soochow University | 2023-04-01 |
| The Relationship Between Self-disclosure, Perceived Social Support and Reproductive Concerns (NCT05914181) | The First Affiliated Hospital of Soochow University | 2023-03-20 |
| PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT (NCT05772273) | The First Affiliated Hospital of Soochow University | 2023-03-15 |
| FMT in Transplant-related Gastrointestinal Mucositis (NCT07622849) | The First Affiliated Hospital of Soochow University | 2023-03-01 |
| Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients (NCT05951855) | The First Affiliated Hospital of Soochow University | 2023-03-01 |
| Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML (NCT05805098) | The First Affiliated Hospital of Soochow University | 2023-03-01 |
| Efficacy and Safety of Autologous Cryopreserved Platelets in Patients With PTR (NCT05761457) | The First Affiliated Hospital of Soochow University | 2023-03-01 |
| Pro-miniCHOP-like Regimen for Treatment-naive Elderly Patients (NCT05809180) | The First Affiliated Hospital of Soochow University | 2023-01-04 |
| M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia (NCT05739630) | The First Affiliated Hospital of Soochow University | 2023-01-01 |
| Deep Learning in Classifying Bowel Obstruction Radiographs (NCT06321614) | The First Affiliated Hospital of Soochow University | 2022-12-31 |
| Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation (NCT05634915) | The First Affiliated Hospital of Soochow University | 2022-12-20 |
| ThisCART19A Bridging to alloHSCT for R/R B-ALL (NCT05679687) | The First Affiliated Hospital of Soochow University | 2022-12-01 |
| ThisCART19A for B-NHL Relapsed After Auto-CAR T (NCT05691153) | The First Affiliated Hospital of Soochow University | 2022-12-01 |
| Construction of a Database for TMA (NCT05634928) | The First Affiliated Hospital of Soochow University | 2022-12-01 |
| The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis (NCT06031363) | The First Affiliated Hospital of Soochow University | 2022-11-01 |
| Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML (NCT05654194) | The First Affiliated Hospital of Soochow University | 2022-10-31 |
| The Use of Eltrombopag Post HSCT in BMFD (NCT05466201) | The First Affiliated Hospital of Soochow University | 2022-10-22 |
| Construction of a Database for TTP (NCT05571774) | The First Affiliated Hospital of Soochow University | 2022-10-20 |
| Aspirin for Prophylaxis of TTP (NCT05568147) | The First Affiliated Hospital of Soochow University | 2022-10-01 |
| CAV Regimen for R/R Ph- B-ALL (NCT05657652) | The First Affiliated Hospital of Soochow University | 2022-10-01 |
| Efficacy and Safety of Daratumumab in Combination With Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma (NCT05561049) | The First Affiliated Hospital of Soochow University | 2022-10-01 |
| CAV Regimen for R/R AML (NCT05657639) | The First Affiliated Hospital of Soochow University | 2022-10-01 |
| Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients (NCT05823701) | The First Affiliated Hospital of Soochow University | 2022-09-30 |
| Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia (NCT05504408) | The First Affiliated Hospital of Soochow University | 2022-09-01 |
| Olverembatinib for FGFR1-rearranged Neoplasms (NCT05521204) | The First Affiliated Hospital of Soochow University | 2022-09-01 |
| This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma. (NCT05486975) | The First Affiliated Hospital of Soochow University | 2022-08-10 |
| Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement (NCT06066840) | The First Affiliated Hospital of Soochow University | 2022-08-01 |
| Orelabrutinib With R-CHOP-like Regimen for Patients With Newly Diagnosed Untreated Non-GCB DLBCL (NCT05498259) | The First Affiliated Hospital of Soochow University | 2022-07-27 |
| Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS (NCT06021210) | The First Affiliated Hospital of Soochow University | 2022-07-07 |
| GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT05797948) | The First Affiliated Hospital of Soochow University | 2022-07-01 |
| AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission (NCT05404906) | The First Affiliated Hospital of Soochow University | 2022-06-25 |
| Avapritinib in CBF-AML With KIT Mutations (NCT05821738) | The First Affiliated Hospital of Soochow University | 2022-06-01 |
| Cohort Construction and Prognostic Model Construction for Multiple Myeloma (NCT06366802) | The First Affiliated Hospital of Soochow University | 2022-05-03 |
| Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients (NCT05433532) | The First Affiliated Hospital of Soochow University | 2022-05-01 |
| Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI346#CIBI346Y001# (NCT05270928) | The First Affiliated Hospital of Soochow University | 2022-04-27 |
| Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients (NCT05376111) | The First Affiliated Hospital of Soochow University | 2022-04-01 |
| Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults (NCT05282719) | The First Affiliated Hospital of Soochow University | 2022-04-01 |
| Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia (NCT05566054) | The First Affiliated Hospital of Soochow University | 2022-03-01 |
| Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma (NCT05322330) | The First Affiliated Hospital of Soochow University | 2022-02-10 |
| Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL (NCT05559450) | The First Affiliated Hospital of Soochow University | 2022-02-01 |
| Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT (NCT05809167) | The First Affiliated Hospital of Soochow University | 2022-01-20 |
| Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT (NCT05823714) | The First Affiliated Hospital of Soochow University | 2022-01-20 |
| Anti-BCMA CAR T-Cell Therapy for R/R ITP (NCT05315778) | The First Affiliated Hospital of Soochow University | 2022-01-01 |
| Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL (NCT05578378) | The First Affiliated Hospital of Soochow University | 2022-01-01 |
| PET / CT Imaging and Safety in Patients With Lymphoma Treated With CD19 Car-t Cells (NCT05176275) | The First Affiliated Hospital of Soochow University | 2022-01-01 |
| Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation (NCT05587881) | The First Affiliated Hospital of Soochow University | 2022-01-01 |
| Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid Leukemia (NCT05023707) | The First Affiliated Hospital of Soochow University | 2021-12-31 |
| GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT (NCT05510505) | The First Affiliated Hospital of Soochow University | 2021-12-30 |
| Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation (NCT05149365) | The First Affiliated Hospital of Soochow University | 2021-12-22 |
| Clinical Efficacy and Safety of CD47 Monoclonal Antibody Combined With Azacitidine in the Treatment of Recurrent AML After Transplantation (NCT05266274) | The First Affiliated Hospital of Soochow University | 2021-12-14 |
| A Single-Arm Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients (NCT05210946) | The First Affiliated Hospital of Soochow University | 2021-12-06 |
| AZA Combined With NAC for PIT After HSCT (NCT05126004) | The First Affiliated Hospital of Soochow University | 2021-12-01 |
| Correlation Between the Efficacy of Neoadjuvant Chemotherapy Combined With Immunotherapy of Operable Thoracic Esophageal Squamous Cell Carcinoma and the Metabolites of Intestinal Flora (NCT05199649) | The First Affiliated Hospital of Soochow University | 2021-12-01 |
| A Study to Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MM (NCT05088330) | The First Affiliated Hospital of Soochow University | 2021-12-01 |
| Avatrombopag to Promote Platelet Engraftment After Allo-HSCT (NCT05143892) | The First Affiliated Hospital of Soochow University | 2021-12-01 |
| Venetoclax Based Regimen for R/R T-ALL (NCT05149378) | The First Affiliated Hospital of Soochow University | 2021-11-01 |
| Investigation of the Gut Microbiota in Acute Myeloid Leukemia Receiving Two Different Induction Therapies (NCT05123352) | The First Affiliated Hospital of Soochow University | 2021-11-01 |
| A Study to Access the Safety and Efficacy of CT0590 in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT05066022) | The First Affiliated Hospital of Soochow University | 2021-10-28 |
| CAV Regimen Bridging to HSCT for R/R AL (NCT05190549) | The First Affiliated Hospital of Soochow University | 2021-10-01 |
| Optimal Adalimumab Plasma Concentrations in Ankylosing Spondylitis Patients (NCT04875299) | The First Affiliated Hospital of Soochow University | 2021-09-01 |
| New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT05029141) | The First Affiliated Hospital of Soochow University | 2021-09-01 |
| Application of Nanopore Sequencing in Newly Diagnosed Acute Myeloid Leukemia Patients With Bloodstream Infection (NCT05016752) | The First Affiliated Hospital of Soochow University | 2021-08-05 |
| CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma (NCT05059912) | The First Affiliated Hospital of Soochow University | 2021-08-05 |
| PBMC Collection for Production of UCAR T Cells (NCT04963959) | The First Affiliated Hospital of Soochow University | 2021-07-14 |
| Outcomes of Patients After Allo-HSCT With Decitabine and NAC (NCT04945096) | The First Affiliated Hospital of Soochow University | 2021-07-01 |
| Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia (NCT04762485) | The First Affiliated Hospital of Soochow University | 2021-06-01 |
| Abatacept s.c. for aGVHD Prevention in Haplo-HCT (NCT04686929) | The First Affiliated Hospital of Soochow University | 2021-06-01 |
| Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD (NCT05140616) | The First Affiliated Hospital of Soochow University | 2021-05-31 |
| Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy (NCT05039580) | The First Affiliated Hospital of Soochow University | 2021-05-15 |
| The Effect of Precise Aerosol Inhalation Nursing on Sputum Excretion in Elderly Patients With Lung Surgery (NCT05025215) | The First Affiliated Hospital of Soochow University | 2021-05-08 |
| Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC. (NCT04882462) | The First Affiliated Hospital of Soochow University | 2021-05-01 |
| Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS (NCT05175508) | The First Affiliated Hospital of Soochow University | 2021-05-01 |
| PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML (NCT04722952) | The First Affiliated Hospital of Soochow University | 2021-05-01 |
| Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL (NCT04846439) | The First Affiliated Hospital of Soochow University | 2021-04-29 |
| Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL (NCT04835870) | The First Affiliated Hospital of Soochow University | 2021-04-01 |
| Efficacy and Safety of Auto-FMT in Preventing aGVHD (NCT04745221) | The First Affiliated Hospital of Soochow University | 2021-03-01 |